---
title: "ICON plc Raises $2.15 Billion in Senior Notes to Refinance Secured Debt"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296253678.md"
description: "ICON plc raised $2.15 billion via senior unsecured notes to refinance secured debt, repaying term loans and redeeming notes due 2027. This shift from secured to unsecured funding released collateral on August 17, 2026. Analysts maintain a 'Hold' rating with a $165 price target, while AI analysis highlights strong cash flow but notes margin compression and high P/E ratios."
datetime: "2026-08-18T13:49:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296253678.md)
  - [en](https://longbridge.com/en/news/296253678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296253678.md)
generator: "portal-rs"
---

# ICON plc Raises $2.15 Billion in Senior Notes to Refinance Secured Debt

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Icon ( (ICLR) ) has shared an update.

On August 13, 2026, ICON Investments Six DAC, a wholly owned subsidiary of ICON plc, issued $2.15 billion of senior unsecured notes in three tranches due 2029, 2031 and 2036, all guaranteed by ICON. The notes were placed privately with institutional investors under Rule 144A and Regulation S, with a registration rights agreement providing for an exchange offer into registered notes with similar terms.

ICON applied the net proceeds between August 13 and August 17, 2026 to repay all outstanding senior secured term loans, redeem its 5.809% senior secured notes due 2027 in full, and retire borrowings under its bridge secured credit facility. Following these repayments, the collateral securing ICON’s revolving credit facility and existing notes, along with subsidiary guarantees under those notes, was automatically released on August 17, 2026, marking a significant shift from secured to unsecured funding in the group’s capital structure.

The most recent analyst rating on (ICLR) stock is a Hold  
 with a $165.00 price target.  
 To see the full list of analyst forecasts on Icon stock,  
 see the ICLR Stock Forecast page. 

**Spark’s Take on ICLR Stock**

According to Spark, TipRanks’ AI Analyst, ICLR is a Neutral.

ICLR scores as moderately attractive: strong cash flow and a healthier balance sheet are the biggest positives, reinforced by strong bookings and maintained guidance. The score is held back by margin compression/earnings variability, a relatively high P/E without dividend support, and only mixed near-term technical strength (below the 20-day average).

To see Spark’s full report on ICLR stock,  
 click here. 

**More about Icon**

ICON plc is an Ireland-based global clinical research organization that provides outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company focuses on designing, managing and running clinical trials and related services for biopharma clients worldwide, supporting drug development and regulatory approvals across major markets.

ICON operates through a network of subsidiaries and financing vehicles, including ICON Investments Six Designated Activity Company and ICON Global Treasury Unlimited Company. Its capital structure includes term loans, senior notes and revolving credit facilities, and the group actively uses U.S. dollar debt issuance to fund operations and refinance existing secured borrowings.

**Average Trading Volume:** 972,280

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $12.59B

Find detailed analytics on ICLR stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [ICLR.US](https://longbridge.com/en/quote/ICLR.US.md)

## Related News & Research

- [ICON sells USD 2.15 billion senior unsecured notes in three-part offering](https://longbridge.com/en/news/296236277.md)
- [ICON announces availability of ICON Cares 2025 ESG report](https://longbridge.com/en/news/296491257.md)
- [Director Of Icon Makes $138K Sale](https://longbridge.com/en/news/295817871.md)
- [ICON (ICLR) Could Be 13% Overvalued On Q1 Earnings And Repeated Outlook](https://longbridge.com/en/news/291799926.md)
- [ICON Restructures Debt and Divests Symphony Ahead of Note Maturities](https://longbridge.com/en/news/294376596.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**